Delcath's Phase III Trial Data To Be Presented During American Society Of Clinical Oncology 2010 Annual Meeting In Chicago

Links shared publicly online about this topic.

  • 1,241
    total visits

Delcath's Phase III Trial Data To Be Presented During American Society Of Clinical Oncology 2010 Annual Meeting In Chicago

medicalnewstoday.com —

Delcath Systems, Inc. (Nasdaq: DCTH), a medical technology company testing its proprietary treatment system for primary and metastatic cancers to the liver, announced that the American Society of

View full resource at medicalnewstoday.com

Tags: Liver, Cancer, Oncology

  • Share

Most Recently Shared on April 15, 2010 at 2:06 am By:

mnt_clinical MNT Clinical Trials

Delcath's Phase III Trial Data To Be Presented During American Society Of Clinical Oncology 2010 Annual Meeting In Chi... http://mnt.to/3BcG

2 years ago...

Reply

Retweet

Favorite

Also Shared By:

Women's Health Line Women's Health Line

MNT Med Conferences MNT Med Conferences

MNT Cancer News MNT Cancer News

Advertisement